Photo: Depositphotos
Jun 27, 2025, 04:38
Cancer Immunotherapy Has Evolved from a Promising Concept into a Mainstay of Oncology Practice – CRI
Cancer Research Institute (CRI) shared on LinkedIn:
“Over the past decade, cancer immunotherapy has evolved from a promising concept into a mainstay of oncology practice, offering new hope amid rising cancer incidence worldwide.
Review the rise in immunotherapy approvals, and discover how immunotherapy is evolving toward more personalized, accessible, and durable treatment strategies in CRI’s Cancer Immunotherapy Insights + Impact report.”
More posts featuring Cancer Immunotherapy.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 10, 2025, 22:13
Aug 10, 2025, 21:48
Aug 10, 2025, 21:21
Aug 10, 2025, 19:51
Aug 10, 2025, 15:36
Aug 10, 2025, 14:54